Pricing Log in Create free account

Greenwich LifeSciences, Inc. (GLSI) vs Immuneering Corporation (IMRX)

Greenwich LifeSciences, Inc. and Immuneering Corporation are both Biotechnology companies. Greenwich LifeSciences, Inc. and Immuneering Corporation are of similar size ($238.3M and $222.7M). Across the 9 metrics below, Immuneering Corporation leads on 5 and Greenwich LifeSciences, Inc. on 4.

Valuation

Metric GLSI IMRX Biotechnology median
P/E n/m n/m 10.60
P/S n/m 751.21 9.40
P/B 71.16 1.41 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales n/m 292.52 9.02
Earnings yield (9.95%) (28.10%) (32.88%)
Free cash flow yield (5.63%) (25.95%) (23.13%)

Profitability

Metric GLSI IMRX Biotechnology median
Gross margin 0.00% 0.00% 68.51%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (986.31%) (33.53%) (51.96%)
Return on assets (374.46%) (31.40%) (46.06%)
Return on invested capital 0.00% (198.38%) 0.00%

Growth

Metric GLSI IMRX Biotechnology median
Revenue growth (TTM) — (84.76%) 6.76%
EPS growth (last fiscal year) (6.72%) 37.75% 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric GLSI IMRX Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 1.54 13.97 4.97
Net debt to EBITDA 0.32 2.94 1.01

Dividend

Metric GLSI IMRX Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric GLSI IMRX Biotechnology median
Market cap 222.67m 238.33m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack